M3, Inc. Stock price

Equities

2413

JP3435750009

Internet Services

Market Closed - Japan Exchange 01:00:00 2024-03-01 am EST 5-day change 1st Jan Change
2,170 JPY +1.07% Intraday chart for M3, Inc. +6.09% -7.01%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 241B 1.61B Sales 2025 * 268B 1.79B Capitalization 1,473B 9.81B
Net income 2024 * 49.59B 330M Net income 2025 * 55.82B 372M EV / Sales 2024 * 5.54 x
Net cash position 2024 * 136B 908M Net cash position 2025 * 162B 1.08B EV / Sales 2025 * 4.89 x
P/E ratio 2024 *
29.7 x
P/E ratio 2025 *
26.4 x
Employees 10,533
Yield 2024 *
0.94%
Yield 2025 *
1.04%
Free-Float 60.21%
More Fundamentals * Assessed data
Dynamic Chart
M3, Inc. cancelled the offer to acquire a 55% stake in Benefit One Inc. from Pasona Group Inc. and others CI
Benefit One Board Backs Dai-ichi Life Tender Offer MT
Dai-ichi Life reaches deal with Pasona on Benefit One acquisition - Nikkei RE
Jefferies Adjusts M3's Price Target to 2,200 Yen From 2,770 Yen, Keeps at Hold MT
Japanese Shares Snap Winning Streak as US Fed Signals More Rate Cut Delay MT
M3 Books Lower Nine-Month Income Despite Improved Net Sales MT
Japanese Shares End in Red But Hit Fresh 52-Week Peak on Weak Yen MT
M3 Extends Tender Offer Period for Benefit One Amid Talks Over Potential Change in Offer Price MT
Chefaa announced that it has received $5.25 million in funding from Newtown Partners Ltd, Global Brain Co., Ltd., GMS Capital Partners LLC, Verod-Kepple Africa Ventures, M3, Inc. CI
Dai-ichi Life to Submit Higher Rival Bid of 1,800 Yen per Share for Benefit One Buyout MT
M3 Extends Tender Offer Period for Benefit One Shares Amid Competing Offer from Dai-ichi Life MT
M3, Inc. acquired Dr. Bhatia Medical Coaching Institute. CI
Horus HD Co., Ltd. completed the acquisition of 82.05% stake in Visionaryholdings Co., Ltd. from M3, Inc and others. CI
M3, Inc. entered into a share tender agreement to acquire a 55% stake in Benefit One Inc. from Pasona Group Inc. and others for approximately ¥140 billion. CI
Jefferies Adjusts M3's Price Target to 2,770 Yen From 3,400 Yen, Keeps at Hold MT
More news
1 day+1.07%
1 week+6.09%
Current month+1.07%
1 month+5.47%
3 months-7.96%
6 months-25.66%
Current year-7.01%
More quotes
1 week
2 032.00
Extreme 2032
2 213.00
1 month
1 920.50
Extreme 1920.5
2 213.00
Current year
1 920.50
Extreme 1920.5
2 527.50
1 year
1 920.50
Extreme 1920.5
3 492.00
3 years
1 920.50
Extreme 1920.5
8 945.00
5 years
1 727.00
Extreme 1727
10 675.00
10 years
641.00
Extreme 641
10 675.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
President 59 00-09-28
Director/Board Member 52 09-12-31
Members of the board TitleAgeSince
President 59 00-09-28
Director/Board Member 65 14-05-31
Director/Board Member 64 00-09-28
More insiders
Date Price Change Volume
24-03-01 2,170 +1.07% 2,952,800
24-02-29 2,146 -2.01% 3,685,700
24-02-28 2,190 +2.55% 4,620,200
24-02-27 2,136 +1.71% 2,974,100
24-02-26 2,100 +2.69% 3,527,000

Delayed Quote Japan Exchange, March 01, 2024 at 01:00 am EST

More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows: - medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE; - support services to medical institutions (16.5%): - clinical trial related services (10.7%): clinical trial support and clinical trial operations management services; - human resources services (6.6%); - other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites. The balance of sales (24.3%) concerns international activities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,170 JPY
Average target price
2,725 JPY
Spread / Average Target
+25.63%
Consensus
  1. Stock
  2. Equities
  3. Stock M3, Inc. - Japan Exchange
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW